NCT02303808View on ClinicalTrials.gov

Positive Expiratory Pressure During Inhalation of Hypertonic Saline in Patients With Cystic Fibrosis

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Cystic Fibrosis
Interventions
DEVICE

INHALATION WITH PEP DEVICE (Acapella Duet)

Intervention will be performed during 5 consecutive days. The performance order of both arms will be randomized.

Trial Locations (1)

Unknown

Asociación Aragonesa de Fibrosis Quística, Zaragoza

All Listed Sponsors
lead

Universidad San Jorge

OTHER

NCT02303808 - Positive Expiratory Pressure During Inhalation of Hypertonic Saline in Patients With Cystic Fibrosis | Biotech Hunter | Biotech Hunter